The paired Journal of Bacteriology studies dissect why carrying the Tn10 tet determinant on a multicopy plasmid is harmful rather than protective. In strain JA221, a single chromosomal Tn10 confers a tetracycline MIC of 160 µg/ml, whereas the multicopy plasmids pBT1010 and pBT107 yield MICs of only 40 and 30 µg/ml; in B2550 the drop is even steeper (120 → 10 µg/ml). Hypersensitivity to inducers is more dramatic: anhydrotetracycline MICs fall from 18 µg/ml (chromosomal tet) to 0.4 µg/ml with pBT1010 in JA221, and from 6.0 to 0.16 µg/ml in B2550—roughly a 40-fold sensitization ().
Y-axis is logarithmic. Data are from the reported agar-dilution MIC table for strain JA221 (comparable B2550 trends replicate the finding); ZnCl2 potentiates inducer toxicity, dropping ATc MICs further ().
The authors rule out simple protein-synthesis inhibition and instead show, via minicell [35S]methionine labeling and tetA-lacZ fusions, that both anhydrotetracycline and heated chlortetracycline strongly induce TetA and TetR synthesis; the induced overproduction of TetA at the cytoplasmic membrane is proposed to inhibit growth (). The companion paper genetically tests this: of 20 spontaneous Atr (anhydrotetracycline-resistant) mutations in pBT107, 18 leave TetR repressor function intact, and insertion mutations cluster within a 150-bp promoter-proximal segment of the tetA promoter. Mosaic-plasmid mapping localizes Atr mutations to the 685-bp XbaI–EcoRI fragment spanning the tetR–tetA promoters, and a tetR deletion plasmid is viable only with a compensating promoter-down mutation in tetA (). Atr plasmids can also act in trans, reducing or abolishing resistance from a chromosomal Tn10—consistent with a shared, titratable toxic efflux component ().
This gene-dosage toxicity principle anticipates modern fitness-based models of MFS efflux pumps, where growth rate directly reports TetB expression and pumping burden (), and it explains why the TetR–tetO switch later became the dominant inducible-expression platform rather than uncontrolled tetA expression (). Limitations: both studies use only two E. coli K-12 backgrounds with unreported replicate counts; the TetA-toxicity mechanism is inferred from genetics and minicell labeling rather than directly quantified in intact cells; and generalization beyond E. coli K-12 and pBT plasmid contexts was untested. Copy-number variation of pBR322-derived plasmids is an uncontrolled variable. Later work confirms the mechanistic picture is broadly right—each tetracycline generation exerts distinct selection on tet mechanisms, with efflux pumps favored by first-generation drugs ()—but the precise molecular basis of TetA overexpression toxicity (e.g., proton-motive-force dissipation vs membrane insertion burden) was never resolved in these papers. Falsification would require showing TetA-induction-independent growth arrest, or that Atr mutations cluster outside the tetA promoter region in independent plasmid contexts.
Author names were not supplied in the source records; use these paper-title queries instead:
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.